The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
Matthew D. J. Dicks(University of Oxford), Matthew G. Cottingham(University of Oxford), Alexandra J. Spencer(University of Oxford), Adrian V. S. Hill(Jenner Institute), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Efrain Guzman, Bryan Charleston(The Pirbright Institute)
Cited by 32
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661